Vera Therapeutics, Inc. — Director's Dealing 2021

May 14, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-13

Reporting Person: Curley Joanne (Chief Development Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	23733	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$6.3728	2030-03-31	Class A Common Stock (25891)		Direct
Stock Option (right to buy)	$2.8968	2030-12-15	Class A Common Stock (66022)		Direct

Footnotes

F1: 1/4 of the shares subject to the option vested on March 12, 2021, and 1/48 of the shares vest monthly thereafter.

F2: 1/4 of the shares subject to the option vest on December 16, 2021, and 1/48 of the shares vest monthly thereafter.